Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001432453-11-000121

Options or other derivatives

  • Director bought 285,714 shares at $0.40 ($114,286)

From the SEC's structured data for this filing

Trades in this filing

DEMARTINI DAVID · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2011-12-02 Purchase : show line 1 in the form Convertible Debenture +285,714 $0.40 $114,286 $0.40 2012-12-02 285,714 285,714 D
Loading xslF345X03/primary_doc.xml…